AmbioPharm
  • About
    • About Us
    • Management Team
  • Science
    • Technology/Expertise
    • Pipeline/Assets
  • News
    • News/Press Releases
  • Contact

Sitemap

Posts

  • Adalvo announces successful launch of Icatibant in close collaboration with strategic partner Ambio
  • Triple Play: A Look at Agonists in Insulin Production
  • Biosimilars
  • Regulatory Aspects for Peptides
  • Apotex Corp. Launches Teriparatide Injectable for Osteoporosis Treatment in the United States (with exclusive co-development partner, Ambio, Inc.)
  • Ambio Announces US FDA Approval of a Generic Version of Forteo® (Teriparatide Injection) for its partner Apotex

Pages

  • Home
  • About Us
    • Management Team
  • Science
    • Pipeline/Assets
    • Technology/Expertise
  • News/Press Releases
  • Contact
  • Sitemap
  • Resources For Employees
  • Careers

Categories

  • News & Press
  • Resources

AmbioRx

Peptide Drug Development Experts

  • About Us
  • Technology/Expertise
  • Pipeline/Assets
  • Resources For Employees
  • News/Press Releases
  • Contact
  • Careers
CONTACT US
Copyright © 2025 Ambio Inc.   |   Sitemap   |   Privacy Policy   |   Cookie Policy